nw-1029 has been researched along with Peripheral-Nervous-System-Diseases* in 1 studies
1 other study(ies) available for nw-1029 and Peripheral-Nervous-System-Diseases
Article | Year |
---|---|
Ralfinamide. Newron Pharmaceuticals.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Fluorobenzenes; Humans; Pain; Peripheral Nervous System Diseases; Sodium Channel Blockers; Structure-Activity Relationship | 2004 |